Nasdaq

Amneal Wins FDA Nod For Epinephrine Injection In Single-and Multi-Dose Vials

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.
Monthly Prescribing Reference

Xylocaine With Epinephrine Injection

Lidocaine HCl 5mg/mL with epinephrine 1:200000, 10mg/mL with epinephrine 1:100000, 20mg/mL with epinephrine 1:100000; soln; contains methylparaben, sodium metabisulfite. See full labeling for ...
Business Insider

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals

BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Yahoo

FDA approves first-ever nasal spray for life-threatening allergies

If you, your child or a loved one are managing a life-threatening allergy, then you know what it’s like to have an EpiPen or Auvi-Q stashed in every bag to ward off anaphylaxis. The injectable ...